253 related articles for article (PubMed ID: 11719215)
21. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.
Davis VL; Shaikh F; Gallagher KM; Villegas M; Rea SL; Cline JM; Hughes CL
Horm Cancer; 2012 Dec; 3(5-6):227-39. PubMed ID: 22968785
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of the PEA3 subfamily of ETS transcription factors in the mouse ovary and peri-implantation uterus.
Koo TB; Song H; Moon I; Han K; Chen C; Murphy K; Lim H
Reproduction; 2005 May; 129(5):651-7. PubMed ID: 15855628
[TBL] [Abstract][Full Text] [Related]
24. Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells.
Galiè M; Sorrentino C; Montani M; Micossi L; Di Carlo E; D'Antuono T; Calderan L; Marzola P; Benati D; Merigo F; Orlando F; Smorlesi A; Marchini C; Amici A; Sbarbati A
Carcinogenesis; 2005 Nov; 26(11):1868-78. PubMed ID: 15975963
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
[TBL] [Abstract][Full Text] [Related]
26. The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development.
Kurpios NA; MacNeil L; Shepherd TG; Gludish DW; Giacomelli AO; Hassell JA
Dev Biol; 2009 Jan; 325(1):106-21. PubMed ID: 18977342
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
28. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA
Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825
[TBL] [Abstract][Full Text] [Related]
29. MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer.
Callahan R
Breast Cancer Res Treat; 1996; 39(1):33-44. PubMed ID: 8738604
[TBL] [Abstract][Full Text] [Related]
30. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
31. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM
Cancer Res; 1998 Dec; 58(23):5500-6. PubMed ID: 9850086
[TBL] [Abstract][Full Text] [Related]
32. Gene expression array analyses predict increased proto-oncogene expression in MMTV induced mammary tumors.
Popken-Harris P; Kirchhof N; Harrison B; Harris LF
Virus Res; 2006 Aug; 119(2):177-86. PubMed ID: 16469401
[TBL] [Abstract][Full Text] [Related]
33. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
[TBL] [Abstract][Full Text] [Related]
34. CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models.
Cremers N; Neeb A; Uhle T; Dimmler A; Rothley M; Allgayer H; Fodde R; Sleeman JP; Thiele W
PLoS One; 2016; 11(3):e0151468. PubMed ID: 26978528
[TBL] [Abstract][Full Text] [Related]
35. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED
Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of Muc1 in MMTV-c-Neu tumors.
Adriance MC; Gendler SJ
Oncogene; 2004 Jan; 23(3):697-705. PubMed ID: 14737104
[TBL] [Abstract][Full Text] [Related]
37. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice.
Ma Z; Parris AB; Xiao Z; Howard EW; Kosanke SD; Feng X; Yang X
J Exp Clin Cancer Res; 2017 Jan; 36(1):6. PubMed ID: 28061785
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors.
Monté D; Baert JL; Defossez PA; de Launoit Y; Stéhelin D
Oncogene; 1994 May; 9(5):1397-406. PubMed ID: 8152800
[TBL] [Abstract][Full Text] [Related]
39. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours.
Davies MP; Rudland PS; Robertson L; Parry EW; Jolicoeur P; Barraclough R
Oncogene; 1996 Oct; 13(8):1631-7. PubMed ID: 8895508
[TBL] [Abstract][Full Text] [Related]
40. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM; Shackleford GM
Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]